Sign up to save your podcasts
Or
Share The Gist: Evening Analysis - Political and electoral tensions in Europe and France | July 09
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Gist: Evening Analysis - Political and electoral tensions in Europe and France | July 09
Today's essential intelligence covering international developments and European affairs. Pharma Pivot
Merck is paying $10 billion in cash for UK-listed Verona Pharma to secure a late-stage COPD drug as Keytruda patents start to expire in 2028 (Bloomberg). Italy’s Paycheck Drought Deepens
OECD’s Employment Outlook flags Italian real wages at -7.
Merck is paying $10 billion in cash for UK-listed Verona Pharma to secure a late-stage COPD drug as Keytruda patents start to expire in 2028 (Bloomberg). Italy’s Paycheck Drought Deepens
OECD’s Employment Outlook flags Italian real wages at -7.
View all episodes
By The GIst AI EditorToday's essential intelligence covering international developments and European affairs. Pharma Pivot
Merck is paying $10 billion in cash for UK-listed Verona Pharma to secure a late-stage COPD drug as Keytruda patents start to expire in 2028 (Bloomberg). Italy’s Paycheck Drought Deepens
OECD’s Employment Outlook flags Italian real wages at -7.
Merck is paying $10 billion in cash for UK-listed Verona Pharma to secure a late-stage COPD drug as Keytruda patents start to expire in 2028 (Bloomberg). Italy’s Paycheck Drought Deepens
OECD’s Employment Outlook flags Italian real wages at -7.